Literature DB >> 34783078

Cellular Nanosponges for Biological Neutralization.

Shuyan Wang1, Dan Wang1, Yaou Duan1, Zhidong Zhou1, Weiwei Gao1, Liangfang Zhang1.   

Abstract

Biological neutralization represents a general strategy that deploys therapeutic agents to bind with harmful molecules or infectious pathogens, block their bioactivity, and thus prevent them from causing the diseases. Here, a comprehensive review of using cell-membrane-coated nanoparticles, namely "cellular nanosponges," as host decoys for a wide range of biological neutralization applications is provided. Compared to traditional neutralization strategies, the cellular nanosponges stand out by mimicking susceptible host cells rather than accommodating the structures of the causative agents for the design of therapeutics. As all pathological agents must interact with host cells for bioactivity, nanosponges bypass the diversity of these agents and create function-driven and broad-spectrum neutralization solutions. The review focuses on the recent progress of using this new nanomedicine platform for neutralization against five primary pathological agents, including bacterial toxins, chemical toxicants, inflammatory cytokines, pathological antibodies, and viruses. Existing studies have established cellular nanosponges as versatile tools for biological neutralization. A thorough review of the cellular nanosponge technology is expected to inspire more refined cellular nanosponge designs and unique neutralization applications to address unsolved medical problems.
© 2022 Wiley-VCH GmbH.

Entities:  

Keywords:  cell-membrane-coated nanoparticle; countermeasures; detoxification; nanomedicine; nanotechnology

Mesh:

Substances:

Year:  2022        PMID: 34783078     DOI: 10.1002/adma.202107719

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  2 in total

Review 1.  Application of Organoids in Carcinogenesis Modeling and Tumor Vaccination.

Authors:  Zeyu Wang; Shasha Zhao; Xiaolin Lin; Guanglong Chen; Jiawei Kang; Zhongping Ma; Yiming Wang; Zhi Li; Xiuying Xiao; Aina He; Dongxi Xiang
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 6.244

Review 2.  Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system.

Authors:  Chutong Tian; Shunzhe Zheng; Xinying Liu; Ken-Ichiro Kamei
Journal:  J Nanobiotechnology       Date:  2022-07-20       Impact factor: 9.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.